Metergoline
SIGMA/M3668
Synonym: N-CBZ-[(8β)-1,6-Dimethylergolin-8-yl]methylamine; [(8β)-1,6-Dimethylergolin-8-yl)methyl]carbamic acid phenylmethyl ester
CAS Number: 17692-51-2
Empirical Formula (Hill Notation): C25H29N3O2
Molecular Weight: 403.52
EC Number: 241-686-3
MDL Number: MFCD00153829
Linear Formula: C25H29N3O2
Product Type: Chemical
| InChI | 1S/C25H29N3O2/c1-27-14-18 |
| InChI key | WZHJKEUHNJHDLS-QTGUNEKASA |
| mp | 148-150 °C (lit.) |
| Quality Level | 100 ![]() |
| SMILES string | [H][C@]2(CNC(=O)OCc1ccccc |
| solubility | 0.1 M HCl: 1.4 mg/mL |
| ethanol: 4 mg/mL | |
| H2O: insoluble | |
| storage temp. | −20°C |
| Application: | Metergoline has been used as a serotonin receptor antagonist: • to study its effects on astrocyte calcium signals evoked by whisker stimulation • to study its effects on lipopolysaccharide-induce • to evaluate the non-specific binding by 5-HT1A receptor binding assays |
| Biochem/physiol Actions: | Metergoline is an ergot alkaloid and a selective serotonin antagonist which blocks the 5-HT2A and 5-HT2C receptors with higher affinity. It possesses antifungal activity against infection caused by Candida krusei. Metergoline exhibits a therapeutic effect against premenstrual dysphoric disorder. It also exhibits antipyretic and analgesic activities. |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 + H312 + H332 |
| Precautionary statements | P261 - P264 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 |
| Hazard Codes | Xn |
| Risk Statements | 20/21/22 |
| Safety Statements | 36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| mp | 148-150 °C (lit.) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


